Development of a point-of-care dual one-step recombinase-aided PCR assay for rapid identification of Mycobacterium tuberculosis gyrA mutations conferring fluoroquinolone resistance
The POCT-DO-RAP assay developed in this study achieves a fully integrated "sample-in, result-out" workflow on a single device, offering ultra-high sensitivity, precise mutation discrimination, and excellent clinical concordance. This approach provides a promising molecular diagnostic tool for rapid detection of drug-resistant tuberculosis, particularly suitable for primary healthcare and resource-limited settings.
Authors
- Qian Ma (ORCID: https://orcid.org/0000-0002-3272-9723)
- Xi Liu (ORCID: https://orcid.org/0000-0002-6741-4094)
- Zijin Zhao
- Duoxiao Zhang
- Yanqing Tie
- Shijue Gao
- Yujie Xiang
- Xinxin Shen
- Jianing Wu
- Shihao Jiao
- Junkai Ren
- Zhiqiang Han
- Xinxin Li
- Xuejun Ma
- Yuanrui Li
- Kenan Peng
Institutions
- Ningbo University (CN)
- Hebei Medical University (CN)
- North China University of Science and Technology (CN)
- Hebei North University (CN)
- HBIS (China) (CN)
- Hebei General Hospital (CN)
- National Institute for Viral Disease Control and Prevention (CN)
- Ningbo College of Health Sciences (CN)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2026-03-02
- DOI
- https://doi.org/10.3389/fmicb.2026.1772984
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Chinese Center for Disease Control and Prevention